このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Upper Limb Exosuit for Clinic Assistance

2021年11月3日 更新者:Tan Tock Seng Hospital

Smart Rehabilitation Exosuits for Clinic and Home Assistance

Aim is to do a feasibility and refinement trial to assess the safety and comfort of the robotic device and their preliminary effect on muscular activity during the performance of activities of daily living.

The study was carried out with 10 stroke participants who had to carry out a series of 10 functional tasks with and without the suit over 3 sessions.

The results are encouraging and show the potential of using wearable robotic devices in a clinical setting.

調査の概要

詳細な説明

Each participant completed 3 ninety-minute long sessions at CART over the course of a week. All participants were closely supervised by 1 occupational therapist and 1 engineer involved in the development of the devices. In the first session, screening of the patient was performed, where the patient's demographics and clinical parameters were collected, including the grip strength of the affected hand measured by a hand dynamometer taking the mean of 2 attempts, and MOCA, FMA and MAS scores. Afterwards, a familiarisation phase was conducted, where the participant trialled the robotic devices to understand their mechanisms and learn how to use them. This phase also allowed the researchers to adjust the fitting of the exoskeletons and tuning the control algorithm of the elbow exoskeleton to the biomechanics of each user, in order to achieve best comfort and assistance.

The participants were instructed to perform a series of elbow/finger flexion and extension movements to understand how to control the exoskeletons. The participants also interacted with different objects (cup, cube, ball) to adjust the positioning of the anchor points in the glove to the position the participants felt most comfortable with. Once the optimised fitting of the devices was identified, the obtained parameters were stored, and the configuration of the devices was left unchanged for reuse in the next session.

In the 2 remaining sessions, participants performed a series of 10 functional tasks. The tasks were performed without assistance (NO-EXO condition) and with assistance (EXO condition) of the exoskeletons. The tasks were performed first in the unpowered condition to allow the participants to familiarise themselves with the tasks before performing them with the assistance of the devices.

The participants were instructed to start every attempt at a task from a position marked on the floor, and with their arms fully relaxed. This was to ensure that variability from unknown factors was minimised. The participants then awaited the instruction from the researchers to commence the task, given in the form of a spoken command triggered by the press of a button. The button was pressed again to signal the end of the task, defined by the following in order of priority: 1) participant decided to stop; 2) the participant dropped the object; 3) therapist decided to stop after deciding the participant was experiencing difficulties and further attempts would not contribute to a successful performance of the task; 4) task is successfully completed.

In addition to the performance of functional tasks, the standing horizontal fingertip reaching distance and the elbow ROM were measured using a measuring tape and a goniometer, respectively.

At the end of the 3rd session, the participants were asked to fill up a questionnaire to provide their subjective feedback regarding comfort, ergonomics, ease of use, overall clinical benefit and user satisfaction.

研究の種類

介入

入学 (実際)

10

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

21年~80年 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Patient with motor deficit(s) due to stroke as diagnosed by CT or MRI, who are attending outpatient rehabilitation services at TTSH Rehabilitation Centre and Centre for Advanced Rehabilitation Therapeutics;
  • Patient with first ever clinical stroke (confirmed on brain imaging);
  • Post stroke of at least 3 months with stable neurological status;
  • Age between 21 to 80 years, inclusive;
  • Hemiplegic pattern and shoulder abduction Medical Research Council motor power > 2/5;
  • Able to give and sign informed consent at research site;
  • Montreal Cognitive Assessment >= 22/30.

Exclusion Criteria:

  • Patient with severe cognitive, perceptual (include hemi-neglect), and/or emotional-behavioural issues that preclude participation;
  • Experiencing moderate to severe levels of pain (visual numeric pain rating scale > 5);
  • Has unstable or terminal medical conditions which may affect participation (e.g. unresolved sepsis, postural hypotension, end stage renal failure) or anticipated life expectancy of < 1 year due to malignancy or neurodegenerative disorder;
  • Non-stroke related causes of arm motor impairment;
  • Local factors which may be worsened by arm therapy or device interface: spasticity of MAS > 3, unhealed skin wounds/rashes, shoulder pain visual analog scale > 5/10, active fractures or arthritis or fixed flexion contractures of shoulder, elbow, wrist or fingers incompatible with device interface;
  • Inability to tolerate 90 minutes of therapy session;
  • Pregnancy or breast feeding;
  • Detectable sensory impairment of affected limb---hemianesthesia to sharp pain.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:デバイスの実現可能性
  • 割り当て:なし
  • 介入モデル:単一グループの割り当て
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
他の:Refinement and Feasibility Trial

It is intra - individual comparison study

Arm 1: participant wore the custom-made upper limb exosuit and hand exoskeleton to perform the series of tasks Arm 0: participant perform the same tasks without the custom-made upper limb exosuit and hand exoskeleton.

Participants go through 3 90-min sessions in a clinic setting and perform a series of functional tasks adapted from motor activity log and bilateral upper limb tasks with and without the device.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Assessment of the elbow module by self-reported evaluation via questionnaire
時間枠:End of the 3rd session, median duration of 5 days from baseline
Patient self-reported outcome of the ease of use, ranked from 1 to 5, 5 being the easiest and 1 being the least easy.
End of the 3rd session, median duration of 5 days from baseline
Assessment of the hand module by self-reported evaluation via questionnaire
時間枠:End of the 3rd session, median duration of 5 days from baseline
Patient self-reported outcome of the ease of use, ranked from 1 to 5, 5 being the easiest and 1 being the least easy.
End of the 3rd session, median duration of 5 days from baseline
Successful completion of tasks (without intervention)
時間枠:At 2nd session, median time of 2 days from baseline
The success of the tasks without the assistance of the exoskeletons was evaluated by the clinician.
At 2nd session, median time of 2 days from baseline
Successful completion of tasks (with intervention)
時間枠:At 3rd session, median time of 5 days from baseline
The success of the tasks with the assistance of the exoskeletons was evaluated by the clinician.
At 3rd session, median time of 5 days from baseline

二次結果の測定

結果測定
メジャーの説明
時間枠
Upper limb angular trajectory (without intervention)
時間枠:Average over the 2nd session, median time of 2 days from baseline
The upper limb angular trajectories while not wearing the exoskeletons were measured via Inertial Measurement Units (IMUs) to investigate changes in movements of the elbow and shoulder joints.
Average over the 2nd session, median time of 2 days from baseline
Upper limb angular trajectory (with intervention)
時間枠:Average over the 3rd session, median time of 5 days from baseline
The upper limb angular trajectories while wearing the exoskeletons were measured via Inertial Measurement Units (IMUs) to investigate changes in movements of the elbow and shoulder joints.
Average over the 3rd session, median time of 5 days from baseline
Muscular synergies (without intervention)
時間枠:Average over the 2nd session, median time of 2 days from baseline
The muscular synergies of the users while not wearing the exoskeletons were measured by calculating Pearson's correlation coefficient between muscles.
Average over the 2nd session, median time of 2 days from baseline
Muscular synergies (with intervention)
時間枠:Average over the 3rd session, median time of 5 days from baseline
The muscular synergies of the users while wearing the exoskeletons were measured by calculating Pearson's correlation coefficient between muscles.
Average over the 3rd session, median time of 5 days from baseline
Muscular effort (without intervention)
時間枠:Average over the 2nd session, median time of 2 days from baseline
The muscular efforts of the users while not wearing the exoskeletons were measured by surface electromyographic sensors (sEMG), and normalised against the maximum voluntary contraction (MVC) value obtained at the beginning of the session.
Average over the 2nd session, median time of 2 days from baseline
Muscular effort (with intervention)
時間枠:Average over the 3rd session, median time of 5 days from baseline
The muscular efforts of the users while wearing the exoskeletons were measured by surface electromyographic sensors (sEMG), and normalised against the maximum voluntary contraction (MVC) value obtained at the beginning of the session.
Average over the 3rd session, median time of 5 days from baseline

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2020年3月23日

一次修了 (実際)

2020年10月31日

研究の完了 (実際)

2020年10月31日

試験登録日

最初に提出

2021年9月30日

QC基準を満たした最初の提出物

2021年11月3日

最初の投稿 (実際)

2021年11月11日

学習記録の更新

投稿された最後の更新 (実際)

2021年11月11日

QC基準を満たした最後の更新が送信されました

2021年11月3日

最終確認日

2021年11月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • 2018/01358

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する